14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.

      Journal of clinical oncology : official journal of the American Society of Clinical Oncology
      Adolescent, Adult, Aged, Female, Genotype, Glioblastoma, genetics, mortality, Humans, Immunohistochemistry, Male, Microglia, cytology, Middle Aged, Polymorphism, Genetic, Prospective Studies, Receptors, Chemokine, Retrospective Studies

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Few reliable prognostic molecular markers have been characterized for glioblastoma multiforme (GBM), considered the deadliest of human cancers. We hypothesized that genetic polymorphisms in chemokines and their receptors, which together control microglial cell mobilization, may influence survival. Distributions of one polymorphism of the chemokine CCL2 (-2518A

          Related collections

          Author and article information

          Comments

          Comment on this article